Vaso Stock

Vaso Debt/EBITDA

The Total Debt to EBITDA Ratio of Vaso (VASO) as of Aug 8, 2026 is 0.01. In the previous year, Total Debt to EBITDA Ratio was 0.03 — a change of -45.65% (lower).

Debt/EBITDA

0.01

YoY

-45.65%

Last updated:

Total Debt to EBITDA Ratio of Vaso is 2026 0.01 . Total Debt to EBITDA Ratio of Vaso was 2025 0.03 . It decreases by -45.65% lower compared to the previous year.
Access this data via the Eulerpool API

Vaso Stock analysis

What does Vaso do? Vaso Corp is a US-American company that was founded in 1987 and is headquartered in New York. The company is publicly traded and specializes in various areas of the healthcare industry. It operates in three segments: medical devices, clinics and clinic providers, and software and services. Vaso is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vaso stock

Total Debt to EBITDA Ratio of Vaso is 0.01 in 2026.

Total Debt to EBITDA Ratio of Vaso changed from 0.03 to 0.01, representing a -45.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Vaso since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Vaso with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Vaso

All Key Metrics — Vaso